TBRA
Morgan Stanley’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-16,614
| Closed | -$661K | – | 6687 |
|
2016
Q3 | $661K | Buy |
16,614
+15,614
| +1,561% | +$621K | ﹤0.01% | 4344 |
|
2016
Q2 | $13K | Sell |
1,000
-12,729
| -93% | -$165K | ﹤0.01% | 6001 |
|
2016
Q1 | $112K | Buy |
13,729
+5,110
| +59% | +$41.7K | ﹤0.01% | 5267 |
|
2015
Q4 | $87K | Sell |
8,619
-97,982
| -92% | -$989K | ﹤0.01% | 5481 |
|
2015
Q3 | $1.03M | Buy |
106,601
+60,284
| +130% | +$582K | ﹤0.01% | 4081 |
|
2015
Q2 | $799K | Buy |
46,317
+45,129
| +3,799% | +$779K | ﹤0.01% | 4369 |
|
2015
Q1 | $1K | Sell |
1,188
-39,246
| -97% | -$33K | ﹤0.01% | 6515 |
|
2014
Q4 | $37K | Buy |
40,434
+36,805
| +1,014% | +$33.7K | ﹤0.01% | 5897 |
|
2014
Q3 | $4K | Sell |
3,629
-10,428
| -74% | -$11.5K | ﹤0.01% | 6377 |
|
2014
Q2 | $96K | Buy |
14,057
+11,099
| +375% | +$75.8K | ﹤0.01% | 5519 |
|
2014
Q1 | $37K | Sell |
2,958
-29,062
| -91% | -$364K | ﹤0.01% | 5816 |
|
2013
Q4 | $153K | Sell |
32,020
-44,808
| -58% | -$214K | ﹤0.01% | 5160 |
|
2013
Q3 | $514K | Buy |
+76,828
| New | +$514K | ﹤0.01% | 4309 |
|